---
document_datetime: 2023-09-21 17:39:46
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/somatropin-biopartners-epar-all-authorised-presentations_en.pdf
document_name: somatropin-biopartners-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.105765
conversion_datetime: 2025-12-28 01:00:25.980326
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## EMA Number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Content (concentration) Pack size

| EU/1/13/849/001   | Somatropin Biopartners   | 2 mg   | Powder and solvent for prolonged-release suspension for                     | Subcutaneous use        | powder: vial (glass); solvent: vial (glass)   | powder: 2 mg; solvent: 1.5 ml   | 4 vials + 4 vials   |
|-------------------|--------------------------|--------|-----------------------------------------------------------------------------|-------------------------|-----------------------------------------------|---------------------------------|---------------------|
| EU/1/13/849/002   | Somatropin Biopartners   | 4 mg   | injection Powder and solvent for prolonged-release suspension for           | Subcutaneous use        | powder: vial (glass); solvent: vial (glass)   | powder: 4 mg; solvent: 1.5 ml   | 4 vials + 4 vials   |
| EU/1/13/849/003   | Somatropin Biopartners   | 7 mg   | injection Powder and solvent for prolonged-release suspension for injection | Subcutaneous use longer | powder: vial (glass); solvent: vial (glass)   | powder: 7 mg; solvent: 1.5 ml   | 4 vials + 4 vials   |
| EU/1/13/849/004   | Somatropin Biopartners   | 10 mg  | Powder and solvent for prolonged-release suspension for injection no        | Subcutaneous use        | powder: vial (glass); solvent: vial (glass)   | powder:10 mg; solvent: 1.5 ml   | 1 vial +1 vial      |
| EU/1/13/849/005   | Somatropin Biopartners   | 10 mg  | Powder and solvent for prolonged-release suspension for                     | Subcutaneous use        | powder: vial (glass); solvent: vial (glass)   | powder:10 mg; solvent: 1.5 ml   | 4 vials + 4 vials   |
| EU/1/13/849/006   | Somatropin Biopartners   | 20 mg  | injection Powder and solvent for prolonged-release suspension for product   | Subcutaneous use        | powder: vial (glass); solvent: vial (glass)   | powder: 20 mg; solvent: 1.5 ml  | 1 vial +1 vial      |
| EU/1/13/849/007   | Somatropin Biopartners   | 20 mg  | injection Powder and solvent for prolonged-release suspension for injection | Subcutaneous use        | powder: vial (glass); solvent: vial (glass)   | powder: 20 mg; solvent: 1.5 ml  | 4 vials + 4 vials   |